Page results
-
This page explains how PIFU will work for you once you have finished your treatment for lymphoma.
-
UCLH has received excellent results in the 2023 National Adult Inpatient Survey this year, with patients rating their overall care 8.8 out of 10. This is an improvement on last year's score of 8.7 and once again makes us the best performing acute/combined trust in England.
-
This information explains radium-223 therapy treat available at University College Hospital.
-
Our new report shows the difference charitable funds can make to patients, staff and research at UCLH
-
This page provides information about an interventional procedure called an Epidural Fibrin Patch. It is intended for use by patients (or their family or carers), who have been referred to the NHNN.
-
A lung cancer patient at UCLH is the first to receive a novel cancer vaccine designed to prime the immune system to recognise and fight cancer cells.
-
This page explains what parathyroid surgery is and gives some information about what it involves.
-
This patient information includes different relaxation techniques which patients being seen by the Post-COVID Service team may find useful.
-
UCLH is committed to following a set of principles on how the trust will use routinely collected patient data for research. The principles will enable vital health research to take place, while at the same time protecting and using clinical data as patients would expect.
-
This page explains more about the Prostate One-Day Clinic and what you can expect when you come for your appointment. If you have any questions about your appointment or the information included on this page, please contact one of our prostate clinical nurse specialists (CNSs).
File results
-
FOI/2022/0205 - Spending on communication activities
-
FOI/2022/206 - Rates for Bonham Carter House 52-54 Gower Street
-
FOI/2022/0207 - Patient treatment with Nivolumab
-
FOI/2022/0209 - Patient tracking list or waiting lists
-
FOI/2022/0211 - Enteral feeding machine mechanical insufflator
-
FOI/2022/0212 - Clotting disorders medication
-
FOI/2022/0214 - Prostate Cancer (Summary Funding and costs of Xtandi (Enzalutamide) trial: NCT00974311) Xtandi (Enzalutamide) trial, NCT00974311
-
FOI/2022/0217 - Medications for dermatological conditions
-
FOI/2022/0221 - Asthma medications
-
FOI/2022/0223 - Policies/ procedures for management of patients with chest pain